A randomized clinical trial of selective laser trabeculoplasty (SLT) in medically uncontrolled open angle glaucoma who had been previously treated with complete SLT

一项针对既往接受过完全 SLT 治疗且药物无法控制的开角型青光眼的选择性激光小梁成形术 (SLT) 的随机临床试验

• 批准号: 253933
• 负责人: Hodge William G
• 金额: $ 55.11万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-03-01 至 2015-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=253933&lang=en
• 关键词: Adverse Events; Argon Laser Trabeculoplasty (Alt); Intraocular Pressure (Iop); Open Angle Glaucoma (Oag); Rct; Selective Laser Trabeculoplasty (Slt); Visual Acuity

Lasers are important therapy in glaucoma. They are a pivotal point in treatment between medical and surgical care. Over the last 10 years a new laser has emerged as the usual laser treatment: Selective laser trabeculoplasty (SLT). SLT works as well as the

激光是青光眼的重要治疗方法。它们是介于内科和外科治疗之间的关键治疗点。在过去的10年里，一种新的激光已经成为常用的激光治疗：选择性激光小梁成形术。SLT和